Mouse listeriosis is a widely used model for the study of host resistance mechanisms that are expressed against intracellular bacteria. The importance of gamma interferon (IFN-␥) and tumor necrosis factor (TNF) in host anti-Listeria resistance in mice has been extensively studied. Buchmeier and Schreiber (4) showed that listeriosis was exacerbated in mice treated with anti-IFN-␥ monoclonal antibody (MAb). Work carried out in this laboratory (15, 16) and in others (28) showed that anti-TNF antibody treatment of mice converted a normally immunizing infection initiated by the intravenous injection of a sublethal Listeria monocytogenes inoculum into a lethal infection. Likewise, anti-TNF antibody treatment exacerbated listeriosis in immunoincompetent nude (nu/nu) mice (14, 15) . Gene knockout mice lacking functional membrane receptors for either IFN-␥ or TNF were found to be considerably more susceptible to listeriosis than the wild-type mice (20, 32, 35) .
Most studies investigating host cells and cytokines in antiListeria resistance have involved mice infected by parenteral routes of inoculation; however, L. monocytogenes normally infects the host by translocating from the intestinal lumen and then spreading to internal organs. MacDonald and Carter (24) reported that listeriae present in the lumens of the gastrointestinal tracts of mice were capable of infecting Peyer's patches (PP) in a manner similar to that of Salmonella typhimurium (5) . PP-associated listeriae were shown to be capable of entering mesenteric lymph nodes (MLN), from which listeriae are capable of infecting other internal organs, including the liver and spleen (24) . Moreover, invading listeriae caused intestinal intraepithelial lymphocytes to secrete IFN-␥ (42) . In light of these observations and of the knowledge that TNF acts as a cofactor in the induction of IFN-␥, experiments were carried out to determine whether IFN-␥ and TNF play roles in innate resistance and specifically acquired antibacterial resistance in the gut-associated lymphoid tissues and other infected organs following the translocation of listeriae from the intestinal lumens of mice.
Mice. Male BALB/c mice 8 to 12 weeks of age were purchased from either Charles River Laboratories (Wilmington, Mass.) or Taconic Farms (Germantown, N.Y.). C.B-17 severe combined immunodeficient (SCID) mice were purchased from Jackson Laboratories (Bar Harbor, Maine). BALB/c mice were maintained under pathogen-free husbandry conditions, while immunoincompetent SCID mice were maintained in autoclaved microisolator cages provided with sterile food and water.
L. monocytogenes. L. monocytogenes (strain EGD, serotype 1/2a) was grown overnight at 37°C in Trypticase soy broth (BBL Microbiology Systems, Becton Dickinson, Cockeysville, Md.). The culture broth was centrifuged at 800 ϫ g for 20 min, and the pelleted bacteria were resuspended in Dulbecco's phosphate-buffered saline (DPBS), pH 7.4. The stock culture, having a titer of 6.6 ϫ 10 9 CFU/ml, was aliquoted in tubes and stored at Ϫ70°C. Immediately before use, stock preparations were quick-thawed and diluted in DPBS (pH 7.4). The intravenous 50% lethal dose for L. monocytogenes in BALB/c Crl mice was determined to be 4 ϫ 10 3 CFU. The standard intragastric (i.g.) inoculum was 2 ϫ 10 8 CFU in 0.2 ml of DPBS. Mice were gavaged i.g. with an 18-gauge feeding needle (Popper, Long Island City, N.Y.).
Enumeration of organ-associated bacteria. Organ homogenates of livers, spleens, MLN, and PP were prepared by grinding organs suspended in iced sterile saline (0.85%) with a motorized Teflon pestle. Enumeration of bacterial CFU in the organ homogenates was determined by plating serial 10-fold dilutions of liver, spleen, or mesentery or mesenteric lymph node homogenates on Trypticase soy agar (BBL Microbiology Systems, Becton Dickinson). Bacterial CFU in homogenates of the Peyer's patches were plated on Listeria-selective phenyl-ethanol (PEA) agar consisting of 1.5% Noble agar, 1.5% Trypticase peptone, 0.5% phytone peptone, 0.5% NaCl, 1.0% glycine, 0.05% LiCl, and 0.25% PEA (24) . When illuminated with oblique light, L. monocytogenes colonies on PEA agar were identified by their characteristic light-blue color. Tests for esculin, catalase, and/or motility were performed to ensure that questionable colonies on PEA agar were indeed L. monocytogenes.
Anticytokine antibodies. The R4-6A2 hybridoma (ATCC HB170), which secretes a rat anti-murine IFN-␥ MAb (immunoglobulin G1 [IgG1]), and the XT3.11 hybridoma (DNAX Research Institute, Palo Alto, Calif.), which secretes rat antimurine TNF-alpha (␣) MAb (IgG1) were grown as ascites in the peritoneal cavities of pristane-primed CB6F 1 mice according to our published procedures (1, 17) . The R4-6A2 anti-IFN-␥ MAb and the XT3.11 anti-TNF MAb were purified from ascitic fluids according to previously published procedures (17) . A rabbit anti-IFN-␥ polyclonal IgG antibody was generated by immunizing a New Zealand White female rabbit with pure recombinant mouse IFN-␥ having a specific activity of 10 7 antiviral U/ml, the kind gift of Genentech, Inc. (South San Francisco, Calif.). The rabbit anti-IFN-␥ IgG or rabbit control IgG was purified from serum according to published procedures (18) . The various purified antibody preparations were assayed for endotoxin concentrations by means of a quantitative chromogenic Limulus amebocyte lysate assay (Whittaker Bioproducts, Walkersville, Md.). The quantification of the anti-IFN-␥-and anti-TNF MAb-neutralizing activities was performed as previously reported (18, 38) .
Anticytokine antibody treatment of mice. Mice were injected intraperitoneally with a given antibody preparation 4 h prior to the i.g. inoculation of bacteria. Mice were injected with 10 5 neutralizing units (NU) of the R4-6A2 rat anti-IFN-␥ MAb (specific activity, 1.8 ϫ 10 5 NU/mg) in PBS (pH 7.4). Mice injected with the XT3.11 rat anti-TNF MAb received 2 ϫ 10 4 NU (specific activity, 6 ϫ 10 3 NU/mg) in PBS (pH 7.4). The mice that were injected with the rabbit anti-IFN-␥ IgG were given 2 ϫ 10 4 NU (specific activity, 2 ϫ 10 3 NU/mg), while the corresponding control mice were injected with an equivalent amount (in milligrams) of control rabbit IgG. At the time of sacrifice, antibody-treated mice were anesthetized and bled by cardiac puncture, and sera were collected and assayed to ensure that excess amounts of the anticytokine were present in the blood throughout the course of the experiments. In all cases, antibody titers exceeded 10 3 NU/ml of blood. Statistical analysis. The experimental results were compared with Student's t test, which requires that the populations be normally distributed and have equal variances. A significant difference between experimental groups was defined by a P value of Ͻ0.05. Experiments involving statistical comparisons were performed with 3 to 5 mice per group.
The importance of TNF and IFN-␥ in resistance to an immunizing Listeria enteric infection. The inhibition of cytokinemediated effects in vivo by the administration specific antibodies has proven effective for establishing the importance of a cytokine in host resistance to infectious agents (4, 8, 15, 16) . Experiments were carried out with specific anti-TNF-or anti-IFN-␥ MAb-treated mice to determine if TNF and IFN-␥ are involved in resistance to enteric listeriosis. Groups of BALB/c mice were injected intraperitoneally with anti-TNF MAb or anti-IFN-␥ MAb and inoculated i.g. 4 h later with 2 ϫ 10 8 CFU of L. monocytogenes. The course of enteric listeriosis was then monitored at progressive times by enumeration of the listerial CFU in the PP, MLN, livers, and spleens of the treated mice and control mice. By the end of the first day of infection, no significant differences existed in numbers of listeriae present in the corresponding organs (MLN, livers, and spleens) of mice in the different experimental groups of mice (data not shown). Moreover, based on the limits of detection of the assay, listeriae were absent from the PP of control mice groups (results not presented). However, by day 3 of infection ( Fig. 1) , the numbers of listeriae in the organs of the anti-TNF MAbtreated mice were greatly exacerbated, whereas numbers of listeriae were elevated only in the MLN of the anti-IFN-␥-treated mice. Also, at this time anti-TNF MAb-treated mice were lethargic and hypothermic, and most died by day 5 of infection. Enumeration of listeriae in the organs of the one remaining anti-TNF MAb-treated mouse on day 5 of infection revealed overwhelming numbers of listeriae in the organs (Fig.  1) . On day 5 of infection, the infected organs of the anti-IFN-␥ MAb-treated mice had greater numbers of listeriae than did the corresponding organs of the control mice. These results establish that the effect of TNF is important in antilisterial resistance during the first 3 days of enteric listeriosis, whereas IFN-␥ mediates an important effect in resistance after this time.
The importance of TNF and IFN-␥ in innate immunity to enteric listeriosis. Results from the foregoing experiment established that an IFN-␥-mediated effect is expressed in Listeria-infected organs of mice after the time (day 3) when the host normally begins to generate a T-cell-mediated anti-Listeria immune response that is capable of resolving infection (25) (26) (27) .
In an attempt to dissociate IFN-␥-or TNF-mediated effects in innate antibacterial immunity from possible effects which could be important in the generation and/or expression of specifically acquired anti-Listeria immunity, immunoincompetent SCID mice were used to determine the importance of these cytokines in innate antibacterial immunity to enteric listeriosis. Groups of C.B-17 SCID mice were inoculated intraperitoneally with anti-TNF MAb or anti-IFN-␥ MAb and inoculated i.g. with 2 ϫ 10 8 CFU of L. monocytogenes 4 h later. Since SCID mice lack discernible PP and MLN, listeriae were enumerated in the mesenteries, livers, and spleens of the MAb-treated SCID mice and control SCID mice on days 3 and 5 of listeriosis. As shown in Fig. 2 , anti-TNF MAb treatment, but not anti-IFN-␥ MAb treatment of SCID mice greatly enhanced numbers of listeriae in the mesentery, liver, and spleen on day 3 of infection. By day 5 of infection, all anti-TNF MAb-treated SCID mice had succumbed to overwhelming infection, whereas infected SCID mice treated with anti-IFN-␥ MAb were only beginning to show signs of morbidity associated with overwhelming bacterial infection. Bacterial numbers present in the mesenteries, livers, and spleens of the anti-IFN-␥ MAb-treated SCID mice and control SCID mice on day 5 of listeriosis are also presented in Fig. 2 , in which the numbers of listeriae in the organs of the anti-IFN-␥-treated mice are shown to be much greater than in the respective organs of control mice. Thus, the results presented in Fig. 1 and 2 collectively establish that the magnitude and temporal manifestation of TNF-and IFN-␥-mediated antibacterial effects are, respectively, similar in the organs of immunocompetent and immunoincompetent mice during enteric listeriosis.
The importance of TNF and IFN-␥ in the expression of antiListeria memory immunity in the intestine. The results of the preceding experiments do not provide evidence as to whether TNF and IFN-␥ function in the expression of anti-Listeria immunity, because similar results were obtained with normal mice and SCID mice undergoing a primary Listeria enteric infection. To determine whether TNF or IFN-␥ plays a role in anti-Listeria immunity in the intestine, Listeria-immune mice immunized by an i.g. inoculation of 2 ϫ 10 8 CFU of L. monocytogenes 28 days earlier were injected intraperitoneally with either anti-TNF MAb or anti-IFN-␥ MAb and challenged with an i.g. dose of 6 ϫ 10 9 CFU of L. monocytogenes 4 h later. Presented in Fig. 3 are the results of this experiment: the CFU in the PP, MLN, livers, and spleens of the MAbtreated Listeria-immune mice on days 3 and 5 of a secondary challenge. On day 3 of infection, listerial numbers were elevated in the organs of the anti-TNF MAb-treated immune hosts relative to those in the corresponding organs of immune control mice (P Ͻ 0.01). At this time, listerial numbers in the respective organs of nonimmune control mice, Listeria-immune control mice, and anti-IFN-␥ MAb-treated Listeria-immune mice were similar. However, by day 5 of infection, listeriae were not detected in the organs of the control Listeriaimmune mice, whereas substantial numbers of listeriae were present in the corresponding organs of the nonimmune control mice, indicating that memory anti-Listeria immunity is not expressed until after the first 3 days of infection. All anti-TNF MAb-treated Listeria-immune mice were dead by day 5 of infection. On day 5, the bacterial numbers in the organs of the anti-IFN-␥ MAb-treated and Listeria-immune mice were only marginally higher than those in the Listeria-immune control mice and were not as high as the bacterial numbers in the organs of the nonimmune control mice. Moreover, the anti-IFN-␥ MAb treatment of immune mice did not completely prevent the expression of immunity, since these mice survived the secondary challenge. This result was not due to a lack of serum anti-IFN-␥ MAb-neutralizing activity during the course of the experiment, for it was found that substantial quantities of anti-IFN-␥ MAb were present in the peripheral circulation of treated mice on day 5 of infection (data not shown). The results of the experiments presented in this study clearly establish roles for TNF and IFN-␥ in anti-Listeria resistance mechanisms that are brought into play during primary and secondary infections caused by listeriae translocating from the gut lumen. Moreover, the results of these experiments not only establish the importance of IFN-␥ in anti-Listeria resistance during enteric infection in immunocompetent and immunoincompetent hosts but also reveal that the IFN-␥-mediated effect occurs in the infected organs after the TNF-mediated effect. In addition, TNF-and IFN-␥-mediated effects in antibacterial resistance occurred, respectively, at corresponding times dur- ing both a primary infection in naive mice and a secondary infection in Listeria-immune mice. In contrast to our findings, Nishikawa et al. (29) reported that IFN-␥-mediated effects occurred during a primary enteric Listeria infection at the same time as TNF-mediated effects.
IFN-␥ is produced by natural killer cells during the first 24 h of listeriosis in mice (10) . However, based on the results of the present experiments with anti-IFN-␥ MAb to neutralize IFN-␥ in Listeria-infected immunocompetent or immunoincompetent hosts, the anti-Listeria effect mediated by this cytokine is not evident until after the third day of infection. This observation raises the question of whether IFN-␥ is involved in the implementation and/or expression of the anti-Listeria resistance mechanism(s). Since the IFN-␥-mediated effect occurs at a time when macrophages populate infectious foci, it seems reasonable to assume that the IFN-␥ is influencing the macrophages' listericidal activity (4, 9) . However, it is also possible that IFN-␥ functions in events that result in the focusing of monocytes/ macrophages at sites of inflammation. With regards to such a possibility, IFN-␥ alone, or in combination with other cytokines, induces the expression of certain beta chemokines (C-C) which can function to focus monocytes to sites of infection (7, 33) .
In addition to its effects on innate antibacterial resistance, IFN-␥ has actions that could be important in the generation and expression of specifically acquired T-cell-mediated antibacterial immunity (2, 19, 21, 39, 40) . As to possible roles for IFN-␥ in the expression of T-cell-mediated immunity, this cytokine is capable of augmenting the activity of specifically sensitized CD8 ϩ cytolytic T cells either directly, by enhancing the activity of these cells (3), or indirectly, by increasing the expression of major histocompatibility complex class I expression on infected target cells (11) . However, it is also important that Harty and Bevan (12) have reported that CD8 ϩ T cells capable of adoptively transferring anti-Listeria immunity are generated during Listeria infection in IFN-␥ gene knockout mice and that Harty et al. (13) found that anti-Listeria CD8 ϩ T cells can protect the host in an IFN-␥-independent manner. These findings seem to suggest that IFN-␥ may not be important in the mediation of anti-Listeria resistance by CD8 ϩ T cells but do not exclude the possibility that IFN-␥ is important in the mediation of anti-Listeria resistance by other phenotypically distinct T cells which have been reported to be protective against this intracellular pathogen (22, 23, 34) .
Following the generation of a primary anti-Listeria immune response, the numbers of T cells capable of adoptively transferring immunity rapidly decline. However, a state of longlived memory immunity ensues. The T cells that are responsible for immunological memory are both physiologically and phenotypically distinct from those that mediate resistance during a primary Listeria infection (30, 31) . In order to establish the importance of IFN-␥ in anti-Listeria T-cell-mediated memory immunity, Listeria immune mice were treated with an anti-IFN-␥ MAb preparation and challenged i.g. with L. monocytogenes. It was found that treatment with an anti-IFN-␥ MAb had little or no effect on the expression of Listeria memory immunity. In view of both this finding and the knowledge that the anti-IFN-␥ MAb exacerbated a primary Listeria infection in either immunocompetent mice (Fig. 1) or immunoincompetent SCID mice (Fig. 2) , it seems reasonable to conclude that IFN-␥ does not function in the expression of anti-Listeria memory immunity. However, the exacerbation of listeriosis during a secondary infection in immune mice treated with an anti-IFN-␥ PAb establishes the importance of this cytokine in the expression of memory immunity. Of interest was the finding that while the anti-IFN-␥ PAb treatment caused an increase in listerial CFU in all organs examined, the extent of the increase was not as great as the increase in CFU in the organs of naive mice (Fig. 4) and anti-IFN-␥ MAb-treated mice during a primary infection (Fig. 1) . These findings indicate that both IFN-␥-dependent and IFN-␥-independent resistance mechanisms serve to resolve the secondary infection. This conclusion is similar to that reached by Samsom et al. (36) , who decided that IFN-␥ played only a minor role in the expression of anti-Listeria immunity against a secondary infection initiated by intravenous inoculation of bacteria. This conclusion was based on results showing that in anti-IFN-␥ MAb-treated memory immune mice, the liver bacterial CFU were only ϳ1 log 10 higher than in control memory immune mice.
The apparent contradiction between the capacities of the anti-IFN-␥ MAb and anti-IFN-␥ PAb to interfere with the expression of anti-Listeria memory immunity may be explained in several ways. First, the antibodies may differ in their affinities for IFN-␥. Second, it is possible that these anti-IFN-␥ preparations exhibit different specificities for distinct molecular domains on the IFN-␥ molecule. Indeed, anti-IFN-␥ MAb preparations have been reported to differ in their abilities to inhibit certain IFN-␥ activities. These findings have been interpreted to mean that different IFN-␥ activities are mediated by distinct functional domains (6, 37) .
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